India Launches New Laboratory For HIV Vaccine Research In Collaboration With IAVI

India on Monday “opened a $12 million, government-backed laboratory whose mission is to create a new vaccine against HIV,” Science Insider reports. “The HIV Vaccine Translational Research Laboratory, which aims to recruit about 30 scientists, is embedded within the Translational Health Science and Technology Institute, a $200 million facility under development on the outskirts of New Delhi” and “will work in collaboration with the New York based-International AIDS Vaccine Initiative (IAVI),” the news service writes, noting “operating costs will be shared equally” (Bagla, 8/14). “Former president A.P.J. Abdul Kalam launched the [laboratory] in New Delhi on Monday at a symposium on accelerating India’s search for an HIV vaccine,” the Wall Street Journal’s livemint.com writes. “Promising ‘strong political will’ at the highest level, health minister Ghulam Nabi Azad said, ‘A preventive vaccine for HIV/AIDS is the best hope to end this epidemic,'” and “added that the step was an initiative to reinforce a national response in the global fight against disease,” the news service notes (Krishnan, 8/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.